Locations:

Uncategorized

February 4, 2020/Cancer/News & Insight

Riding the Cancer Roller Coaster

An oncologist's perspective on dealing with treatment highs and lows

February 3, 2020/Cancer/Research

New Approach Leads to Transfusion Independence in Low-risk MDS

Luspatercept shows promise for patients with few options

February 3, 2020/Digestive/Q&A

Digestive Disease Institute in Abu Dhabi Growing By Leaps and Bounds

Specialty care programs quickly expanding to meet the region’s needs

January 29, 2020/Cancer/Research

NCI Grant to Cleveland Clinic Scientist Will Support Evolution-Based Cancer Research

Searching for new insights into drug resistance, collateral sensitivity

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 23, 2020/Cancer/Research

Top 10 Takeaways from ASH 2019

These research results will have impact in 2020

January 20, 2020/Digestive/Patient Care & Management

Driving After Endoscopic Procedural Sedation: Is a 24-hour Ban Too Long?

Cleveland Clinic study assesses psychomotor recovery

January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

December 20, 2019/Cancer/News & Insight

Moments in Time

For a cancer doctor, patients’ photographs are small windows into their condition

December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

BackPage 2 of 5Next